Exparel 133 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FQAJD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,046
Award facts
- Contract value 100% obligated
- $3,046.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency for 133 mg/10 mL vials of Exparel, a local anesthetic medication commonly used in surgical and pain management applications. This firm fixed-price delivery order, valued at $3,046.10, was awarded on September 3, 2025, with an ultimate completion date of September 24, 2025. The contract includes no set-aside designation, and performance will occur at the vendor's facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion agreement through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and specialty medications to military health systems. The company's robust portfolio of federal contracts reflects its operational capability to support the Defense Logistics Agency's medical supply requirements across multiple product categories and geographic locations.
Quick answers
Who was awarded contract SPE2DB25FQAJD?
SPE2DB25FQAJD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FQAJD worth?
The government has obligated $3,046 on SPE2DB25FQAJD.
Is contract SPE2DB25FQAJD an order under another contract?
Yes. SPE2DB25FQAJD is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB25FQAJD competed?
The extent of competition for SPE2DB25FQAJD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award